Is the higher incidence of clozapine induced myocarditis in Australia due to awareness and monitoring?
暂无分享,去创建一个
[1] L. DeLisi,et al. Potentially fatal outcomes associated with clozapine , 2018, Schizophrenia Research.
[2] J. McNeil,et al. Clozapine‐induced myocarditis, a widely overlooked adverse reaction , 2015, Acta psychiatrica Scandinavica.
[3] A. Wheeler,et al. Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013 , 2015, Pharmacopsychiatry.
[4] J. McNeil,et al. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: A case–control study , 2012, Schizophrenia Research.
[5] Dan Cohen,et al. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy. , 2012, The Journal of clinical psychiatry.
[6] J. McNeil,et al. A New Monitoring Protocol for Clozapine-Induced Myocarditis Based on an Analysis of 75 Cases and 94 Controls , 2011, The Australian and New Zealand journal of psychiatry.
[7] J. McNeil,et al. Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases , 2011, Schizophrenia Research.
[8] D. Celermajer,et al. Myocarditis and cardiomyopathy associated with clozapine , 1999, The Lancet.
[9] J. McNeil,et al. Clozapine-Associated Myocarditis , 2007, Drug safety.